Parkside Financial Bank & Trust - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$0
-100.0%
143
-90.6%
0.00%
-100.0%
Q2 2022$6,0000.0%1,514
+46.7%
0.00%0.0%
Q1 2022$6,000
-50.0%
1,032
+20.3%
0.00%
-33.3%
Q4 2021$12,000858
+4415.8%
0.00%
Q3 2021$0
-100.0%
19
-70.8%
0.00%
Q2 2021$1,0000.0%65
+30.0%
0.00%
Q1 2021$1,0000.0%50
+6.4%
0.00%
Q3 2020$1,0000.0%47
-11.3%
0.00%
Q2 2020$1,0000.0%53
-36.1%
0.00%
Q1 2020$1,0000.0%83
+176.7%
0.00%
Q4 2019$1,0000.0%30
-34.8%
0.00%
Q3 2019$1,000
-50.0%
46
-22.0%
0.00%
-100.0%
Q2 2019$2,0000.0%59
+20.4%
0.00%0.0%
Q1 2019$2,000
+100.0%
49
+88.5%
0.00%
Q4 2018$1,0000.0%26
+52.9%
0.00%
Q3 2018$1,0000.0%17
+13.3%
0.00%
Q2 2018$1,000
-50.0%
15
-21.1%
0.00%
-100.0%
Q1 2018$2,000
-60.0%
19
-79.1%
0.00%
-50.0%
Q4 2017$5,000
+150.0%
910.0%0.00%
+100.0%
Q3 2017$2,0000.0%910.0%0.00%0.0%
Q2 2017$2,0000.0%910.0%0.00%0.0%
Q1 2017$2,000
+100.0%
910.0%0.00%
Q4 2016$1,000910.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders